Current Funding

NIH

R01AI50847- Monitoring and Manipulating the Activity of the Immunoproteasome with Small Molecules- 2020-2024

R21GM131206- ​Development of Activity-Based Chemical Reporters to Differentiate Proteasome Isoforms in Cells- 2019-2021

CTSI- Proteomics

Rpn-13 small molecule binders- 2019-2020

Purdue University Center for cancer research Grants

-Phase I Concept Award, Rpn-13 Inhibitors, 2019-2020
-Shared Resource Grant for Cryo-EM analysis of the proteasome and small molecules, 2019
-Phase II Concept Award, Rpn-6 Inhibitors 2018-2019

Showalter Trust Research Award

"Targeting Cancer Cells with an Immunoproteasome-Selective Prodrug Strategy"- 2019-2020

Purdue MCMP Start-Up

2016-2021

Previous funding

Showalter Trust Research Award

"Discovery of Proteasome Stimulators to Treat Diseases Associated with Protein Accumulation"
2017-2018

MCMP Research Enhancement Award

"Development of a high throughput FRET assay for screening natural products for 20S CP stimulators"
​2017-2018

​Purdue Cancer center grants

-American Cancer Society Institution Grant for New Investigators, 2016-2017
-Phase I Concept Award, Rpn-6 Inhibitors, 2017-2018